Longevity Today
Academic PapersReviewsVideosPodcastsPress ReleasesClinical TrialsDrug ApprovalsTutorialsAnimations
All Articles
Sign In
Deep Dive Audio
Yale Scientists Identify Two Proteins That Drive Parkinson's Spread in the BrainBrain Health

Yale Scientists Identify Two Proteins That Drive Parkinson's Spread in the Brain

Yale researchers have identified two proteins on the surface of brain cells — mGluR4 and NPDC1 — that appear to help the toxic protein linked to Parkinson's disease spread from neuron to neuron. Using a massive screen of 4,400 engineered cell lines, scientists found these proteins act as entry points for misfolded alpha-synuclein, the hallmark of Parkinson's. When mice were genetically engineered to lack these proteins and then exposed to misfolded alpha-synuclein, they showed dramatically less disease progression and preserved dopamine-producing neurons compared to normal mice. The findings, published in Nature Communications, could point toward therapies designed to slow or halt Parkinson's rather than merely managing symptoms.

0:00--:--
Read Full Article
Longevity Today

Developed by the Clinical and Foundational Medicine Institute

AI-powered summaries of the world's best longevity research — from peer-reviewed journals to expert podcasts and YouTube deep-dives. Built for those who take their healthspan seriously.

info@LongevityToday.com

Categories

CancerHeart DiseaseAlzheimer'sParkinson'sDiabetesGut HealthNutritionStrength & FitnessSupplements & PeptidesStem CellsReversing AgingAuto-ImmunityAdvanced Therapies

Platform

  • All Articles
  • Membership Plans
  • Search
  • Newsletter

Newsletter

Weekly longevity research, summarized.

Enter your email to subscribe:

© 2026 Longevity Today. All rights reserved.

About UsPrivacy PolicyTerms of UseMedical Disclaimer

Content on Longevity Today is for informational purposes only and is not intended as medical advice. Always consult a qualified healthcare professional before making health decisions.